page_banner

Products

1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine Acidum carboxylicum ethyl niensis CAS: 503614-91-3

Description:

Catalogue Number: XD93345
Cas: 503614-91-3
Formulae hypotheticae: C27H28N4O5
Pondus hypotheticum: 488.54
Availability: In Stock
Pretium:  
Prepack:  
Mole Pack: Request Quote

 


Product Detail

Product Tags

Catalogue Number XD93345
Product Name 1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine. -3-acidi carboxylici ethyl ester
CAS 503614-91-3
Formulae hypotheticaela C27H28N4O5
M. Pondus 488.54
Repono Details Ambiens

 

Product Specification

Aspectus Pulvis albus
Assay 99% min

 

1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine. -3 Acidum carboxylicum ethyl niensis complexum chemicum compositum est, quod potentiam variis in locis chemiae medicinalis et pharmaci inventio ostendit.Hic descriptio usuum circiter 300 verborum est. Haec compositio, quae saepe refertur ad derivativum ethyl niensis 1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1-yl) phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine-3-acidi carboxylici, ad genus derivatorum pyridini pertinet.Hae derivationes animadverterunt in inventione medicamentorum ob potentias suas in variis locis therapeuticis. Una applicatio potentialis huius compositionis in campo anti-cancri investigationis iacet.Pyrazolo[3,4-c] derivationes pyridines praebuit promittentes anti-proliferativam actionem contra varias cellularum species.Facultas inhibendi vias specificas quae in tumore incrementi ac superstes implicantur, eos potentiales candidatos facit ad medicamenta anti-cancri progressui.Praeterea studia necessaria sunt ad mechanismum actionis explorandum et efficaciam compositi in occasus preclinicis et clinicis aestimandis. Haec autem compositio promissionem ostendit tamquam agens antibacterial potential.Actiositatem contra varios modos bacteria, inter tam gra-positivos quam gram-negativos bacteria, exhibuit.Facultas ad plures modos oppugnandi potentiam suam suggerit in pugnando bacteria pharmaco-repugnando, quae notabilis factae salutis globalis sollicitudinem.Praeterea investigatio suadetur ut eius agendi modum investigare et efficaciam in bacterial contagione pugnans aestimare. Accedit, derivationes pyridines, inclusas hoc compositione, potentiam in inflammatione et autoimmune morborum curatione demonstravisse.Inflammatio munus criticum agit in variis condicionibus, ut arthritis rheumatoidis et psoriasis.Hae derivationes proprietates anti-inflammatorias ostenderunt modulando vias specificas in responsione inflammationis implicatas.Hoc eorum potentiale actores medicinales suggerit ad inflammationem veterem et adiunctos morbos administrandos. Praeterea haec compositio actionem in systemate nervosi centrali ostendit (CNS).In neurologicis perturbationibus eius potentia exploratum est ut morbo Alzheimer et morbo Parkinson.Compositum modulare potest receptores specificos et enzymes in processu morborum implicatos, potentia neuroprotectivos effectus offerens.Attamen adhuc investigatio necessaria est ad plene cognoscendam eius mechanismum agendi eiusque efficaciam aestimandi in his implicatis perturbationibus tractandis. In summa, 1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1- yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylico acidum ethyl niensis promittit in pluribus areis medicinalibus, etiam anti-cancro, antibacterial, anti-inflammatorio. ac perturbationes CNS.Potentiale est in sua facultate certas vias ac receptores oppugnare his conditionibus implicatas.Attamen ulterior investigatio et investigatio necessaria sunt ut eius potentiales, optimize proprietates plene explorent, eius salutem et efficaciam in uncinis clinicis aestimant.


  • Priora:
  • Deinde:

  • Close

    1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine Acidum carboxylicum ethyl niensis CAS: 503614-91-3